A1 milk with the a1 beta-casein variant is a possible risk factor in the development of type 1 diabetes in children, autism, and heart illnesses in adults.
Milos Pokimica
Written By: Milos Pokimica
Medically Reviewed by: Dr. Xiùying Wáng, M.D.
Updated June 10, 2023Key Takeaways:
– Beta-casein is a protein that makes up about 30% of the protein in cow’s milk. It exists in two genetic variants: A1 and A2.
– A1 beta-casein in cow milk is different from all other mammals, which exclusively have A2 type including A2 cattle from India, and Africa, Buffalo, as same as other mammals and the same as human milk. Almost all cattle of the A1 type are related to cows of European origin for the subspecies of the original species of this mutation Bos Taurus.
– BCM7 is a peptide that breaks down from A1 beta-casein into 7 amino acids. It has opiate-like effects similar to narcotics such as morphine and can be harmful to low-density lipoproteins (LDL).
– There is a correlation between type 1 diabetes and antibodies to A1 beta-casein. These antibodies are believed to attack the cells that produce insulin in the pancreas due to similarities with BCM7’s protein structure.
– Casomorphins are opioids that can be found in dairy products, specifically in A1 beta-casein. They have been linked to autism and schizophrenia through the “opioid excess” theory
– Opioid peptides from cows’ milk have long been theorized as a possible cause of sudden infant death syndrome (SIDS), as they may inhibit the respiratory center in the brainstem, leading to apnea and death.
– Elevated basal irBCM (cattle casomorphins) was found in formula-fed infants showing a delay in psychomotor development and heightened muscle tone while the highest basal irHCM (human casomorphins) was observed in breast-fed infants with normal psychomotor development and muscle tone.
A1 beta-casein in cow milk.
Beta-casein is about 30% of the protein in cow’s milk. Beta-casein is present as one or two genetic variants; A1 or A2. Most cow’s milk contains a combination of A1 and A2 beta-casein. However, milk that contains only the A2 type without A1 beta-casein alpha is available in some countries.
The second variant, A2 beta-casein, is not associated with diabetes type 1.
The established relationship of this link between A1 beta-casein and type 1 diabetes, and heart disease is 0.982 and 0.76 (Laugesen and Elliott, 2003).
This is a very significant level if compared with other epidemiological reasons for these conditions, such as smoking and mortality from lung cancer r = 0.73 or the likelihood of people in the 1960s and heart conditions ten years later where r = 0.85.
The difference between A1 and A2 beta-casein is present because of a single amino acid substitution at 67 line of amino acids of 209 that they have in the chain.

A1 beta-casein in cow milk is different from all other mammals, which exclusively have A2 type including A2 cattle from India, and Africa, Buffalo, as same as other mammals and the same as human milk. Almost all cattle of the A1 type are related to cows of European origin for the subspecies of the original species of this mutation Bos Taurus.

It is a result of a genetic mutation in cows in Europe that happened about 8,000 years ago. Today, A1 milk cows are bred in Europe and America, and A2 species are bred in New Zeeland. Holstein species have A1 and A2 beta-casein in almost equal amounts. The Jersey species typically has a little more than A2 but is also considered a mixed species. The same Jersey cows carry a “B” beta-casein that has proven to give more BCM7. Signs of poor histidine attachment, A1 beta-casein breaks down into peptides of 7 amino acids called beta casomorphin 7 (BCM7) when consumed. BCM7 is problematic because opiate is at the same level as narcotics like morphine and has similar effects. It is also an oxidant that is known to be detrimental to low-density lipoproteins (LDL). Because the links between 7 amino acids make it extremely strong, it is resistant to further degradation. When BCM7 enters the bloodstream, various problems arise.

However, the BCM 7 is too large to be absorbed by a healthy coat in the intestine, which means that the health problem associated with A1 beta-casein is more likely to be affected by people with damaged digestive health or from diseases such as celiac disease or gastrointestinal disease.
If you have a leaky gut, then you can give yourself and your fetus if you are pregnant type 1 diabetes as an autoimmune disease. if you consume milk and dairy products, that is. Persons having any of the prevailing conditions are more suitable for abscess BCM7. In babies that naturally have increased intestinal permeability in order to improve the absorption of nutrients, there is a higher risk also.
Once it enters the bloodstream, BCM7 can easily break through the blood-brain barrier and enter the brain, where the connection to the receptors causes the symptoms of autism and schizophrenia.
This claim was initiated by research that was disseminated on rats, where rats showed similar tendencies in behavior and sympathy as autism and schizophrenia after BCM7 injection. The association of these effects was also confirmed by the ability to reverse the state and changes in opioid-antagonistic naloxone behavior. To add to that, it has long been recognized that opiates have an effect on immune function, which is the possible reason why A1 beta-casein and BCM7 are associated with autoimmune diseases.
Heart Disease.
The first discovery was made by Alexandra Steinerovathat have been investigating the reasons behind oxidative stress in infants. She discovered that babies who were fed milk formula had a higher level of antibodies to oxidized LDL (Steinerová et al, 1999). In 2004, Steinerova put forth the idea and did a study on BCM7 and the increase in antibodies in infants. A study demonstrated that infants fed A1 beta-casein baby formula developed significantly higher levels of these antibodies compared to that fed A2 beta-casein (Steinerová et al., 2004).
Today more research had been done and it is excepted in the scientific community that BCM7 has a pro-oxidative effect on LDL. In the case of cardiac diseases, additional studies have uncovered the mechanism by which the A1 beta-casein will develop the cardiac disease, and the primary effect is a BCM7 that oxidizes LDL that transports cholesterol from the liver to the tissues (Chin-Dusting et al., 2006). This is important because the oxidized LDL increases the risk of heart disease as a result of increased artery incidence and as a consequence increased plaque accumulation, ie. oxidized LDL makes arteries sticky and leads to the formation of plaque.
Type 1 Diabetes.
Type 1 diabetes, is classified as an autoimmune disease that occurs due to an immune system assault on cells that produce insulin in the pancreas.
And it is not genetic as you might lead to believe by conventional medicine. Genetic predisposition plays a role but to prove the fact that it is just one more maladaptation we can look at identical twins. The concordance of diabetes type 1 in identical twins is only 50 %. Meaning one gets it one does not. If it is genetic and the environment does not play a role that would not happen. It is something we ate or to be precise mothers ate or give the babies that cause them to develop this autoimmune disease.
In Japan diabetes type 1 is 18 times lower than in the U.S., but when the Japanese migrate to America and start to adopt the Western diet, they develop the same rate of diabetes as Americans. Some countries have 100 times the less diabetes type 1 rates than others depending mostly on the diet the population eats. Type one diabetes started to rise after World War 2 as same as other diseases, so it is not genetics. It is maladaptation, and we now know what is causing it.

In 1999 scholars in Germany discovered that there is a correlation between type 1 diabetes and the level of antibodies to A1 beta-casein. It is believed that these antibodies are, in fact, based on the amino acid sequence of the problematic opioid BCM7, which is derived from A1 beta-casein. Because the sequence has similarities with the protein structure of the cells that produce insulin in the pancreas, the antibodies attack the pancreas together with the BCM7 peptides. In this study, every single kid had significant levels of A1 beta-casein antibodies in their blood but not of antibodies to other milk proteins (Karjalainen et al., 1992). The conclusion was:
“Patients with insulin-dependent diabetes mellitus have immunity to cows milk albumin, with antibodies to an albumin peptide that is capable of reacting with a beta-cell-specific surface protein. Such antibodies could participate in the development of islet dysfunction.”
Karjalainen et al., 1992

Autism, Schizophrenia, and Sudden Infant Death Syndrome.
Also, there are opiates that cross the blood-brain barrier. Because BCM7 opiates should not be present at all and represent a form of unnatural mutation in cattle it should not be a great surprise in the relationship between A1 beta-casein and casein in general to association with autism also.



BCM 7 obtained from A1 beta-casein and gluteomorphin derived from gluten are both opiates that can be associated with these symptoms. Because of this, a huge number of children with autism show significant improvements if they avoid gluten and casein. The relationship between autism and opiates is nothing new. In 1979, Jaak Panksepp, a scientist, suggested that connection. In 2000, a team of researchers led by Robert Cade reviewed the existing evidence linking the casein and gluten opiates with autism and schizophrenia. They collected new data from 150 autistic children, 120 schizophrenia adults, 43 normal children, and 76 normal adults (Cade et al., 2000). Autistic children and schizophrenia adults showed a constant elevated abnormal value of casomorphin and gluteomorphin opioid peptides obtained from beta-casein and gluten.
Actually, all adults show elevated levels of this morphine opioid substance after consumption of milk or yogurt, even the adult that does not have inflammation in the gut at least for 8 hours after consumption (Chabance et al., 1998).
The theory goes something like this. You have a genetic predisposition for diseases such as autism or schizophrenia. This is the so-called “opioid excess” theory. You have a genetic predisposition and then have some early exposure to environmental stressors that damage your gut and make it leaky or you are just a regular baby that naturally has a leaky gut. Then comes the milk or dairy products with all of the casomorphins leaking into the blood in excess and then into the brain triggering disease to form. These opioids are thought that could play one of the roles in the development of autism and other neurological disorders. The problem with these casomorphins is also that when you examine the blood-brain barrier of autism patients, their blood-brain barrier seems weaker too.
In a normal individual, there are going to be some of the sedative effects but in someone with a leaky gut and a leaky blood-brain barrier it is going to have a much stronger effect, and if that person has a genetic predisposition or sensitivity to it then the real disease can form. By the so-called “opioid excess” theory anyway.
Of the seventy autistic children placed on a gluten-free and casein-free diet, 81% showed significant improvements over a period of 3 months, and more than a third of those who did not recover were still high in opioid peptides, indicating that they did not keep the child’s diet. Although only 40% of adults have improved, it is believed that many of them have not been using the diet for long enough to provide their bodies with the ability to eliminate existing BCM7 molecules in the brain that can last for more than a year.
In 1999, Zhongjie Sun and Robert Cade injected BCM7 opioid derivatives from A1 beta-casein into rats to determine if it enters the brain (Cade et al., 1999). They found out that it will enter the various areas of the brain that were previously proven to be associated with autism and schizophrenia. As a consequence, it was reasoned that the BCM7 could break through a blood-brain barrier and hit parts of the brain that are susceptible to those affected by autism and schizophrenia. In the same year, they conducted a similar experiment and found that rats injected with BCM7 exhibited several significant symptoms of autism and schizophrenia such as intolerance, reduced pain sensitivity, and lack of response to external stimuli.
In 2003, Sun and Cade continued their research and discovered that gluteomorphin opioids derived from gluten affect only three regions of the brain while BCM7 opioids derived from A1 beta-casein affected 45 regions and circulation of this peptide into the infant’s immature central nervous system might also inhibit the respiratory center in the brainstem leading to apnea and death (Sun et al, 2003). Opioid peptides from milk have long been theorized as a possible cause of sudden infant death syndrome (Ramabadran and Bansinath, 1988).
This not only proved that BCM7 comes to the brain much more easily but it is a much larger factor in the development of autism and schizophrenia. Are these studies going to lead to more understanding or better treatment of these individuals I do not know. There could be individuals with a genetic predisposition to these diseases that these molecular mimicry proteins only aggravate. I don’t know. Science still doing research but it is a slow process and who will have the interest to finance these studies? It will take some time.
Opoid casomorphins and psychomotor delay.
A1 milk vs A2 milk got a big political issue in Australia and New Zeeland at one point. It ended with obligatory labeling of milk and all dairy products. In Australia, you cannot buy a bottle of A1 milk or any other dairy product without a visible label that shows does the milk contain an A1 or A2 form of protein.

Why are these opioids in the milk in the first place? And there are in all of the milk in existence, not just the A1 milk variant. A1 milk is just a more potent variant. For normal human babies as well as calves, they are there to create a craving or to get them addicted like regular drug addicts are, but in this case, the addiction is going to trigger the baby’s curing for opiates and then the baby is going to get all the nutrition from milk that it needs to grow. It is all as it should be but now we have switched species. Just like the protein amino acid profile of human and cow milk is not the same so the profile of these casomorphins is not the same.
In this study (Kost et al., 2009) the babies fed on cow’s milk with a higher level of bovine casomorphins seem to suffer from psychomotor delay but exactly the reverse was found for human casomorphins. Human casomorphins seams to help the brain of humans. The conclusion of the study was:
“The highest basal irHCM (human casomorphins) was observed in breast-fed infants with normal psychomotor development and muscle tone. In contrast, elevated basal irBCM (cattle casomorphins) was found in formula-fed infants showing a delay in psychomotor development and heightened muscle tone. Among formula-fed infants with normal development, the rate of this parameter directly correlated to basal irBCM. The data indicate that breastfeeding has an advantage over artificial feeding for infants development during the first year of life and support the hypothesis for the deterioration of bovine casomorphin elimination as a risk factor for delay in psychomotor development and other diseases such as autism.”
(Kost et al., 2009)
The structure of casein in human and cow milk is significantly different matching only by 47%, and especially if we have mutated A1 casein in the mix, then we have a situation that can trigger diabetes type 1 in the baby. Bovine casomorphin is much stronger than human one, and it is almost at the level of morphine in its effect (Trivedi et al., 2015). Cow casomorphins bind tighter to the serotonin receptors in the brain than human one does. Also, opioid casomorphins were produced by both A1 and A2 milk with no difference in potency (Asledottir et al., 2017). Also, there is much more casein in general in cow’s milk, 15 times more to be precise than in human’s milk. Twenty-one peptides and eight from beta-casein were found in cow milk, and only five peptides with only one from beta-casein were found in human milk.

Should you switch to A2 which is ten times more expensive? What about pizza with A1 milk cheese or any other commercial A1 milk product? Most of the chocolates are made with A1 milk powder. The most realistic scenario is that even if we want to switch to A2 there is no A2 milk around if you live outside of New Zeeland. And even in New Zeeland, there is the chipset powder A1 milk made for the food industry in almost everything. From ice cream to chocolate. And even if we could spend additional money and have that A2 ice cream, milk is still correlated including A2 to a wide range of health issues (Milk and dairy- Health risk correlations).
The Devil in Milk, Why It Can be Dangerous.
FAQ
References:
- Karjalainen, J., Martin, J. M., Knip, M., Ilonen, J., Robinson, B. H., Savilahti, E., Akerblom, H. K., & Dosch, H. M. (1992). A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. The New England journal of medicine, 327(5), 302–307. https://doi.org/10.1056/NEJM199207303270502
- Chabance, B., Marteau, P., Rambaud, J. C., Migliore-Samour, D., Boynard, M., Perrotin, P., Guillet, R., Jollès, P., & Fiat, A. M. (1998). Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie, 80(2), 155–165. https://doi.org/10.1016/s0300-9084(98)80022-9
- Kost, N. V., Sokolov, O. Y., Kurasova, O. B., Dmitriev, A. D., Tarakanova, J. N., Gabaeva, M. V., Zolotarev, Y. A., Dadayan, A. K., Grachev, S. A., Korneeva, E. V., Mikheeva, I. G., & Zozulya, A. A. (2009). Beta-casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides, 30(10), 1854–1860. https://doi.org/10.1016/j.peptides.2009.06.025
- Trivedi, M. S., Hodgson, N., Walker, S. G., Trooskens, G., Nair, V., & Deth, R. C. (2015). Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells. Nutrition & Metabolism, 12(1). https://doi.org/10.1186/s12986-015-0050-1
- Asledottir, T., Le, T. T., Petrat-Melin, B., Devold, T. G., Larsen, L. B., & Vegarud, G. E. (2017). Identification of bioactive peptides and quantification of β-casomorphin-7 from bovine β-casein A1, A2 and I after ex vivo gastrointestinal digestion. International Dairy Journal, 71, 98-106. https://doi.org/10.1016/j.idairyj.2017.03.008
- Cade, R., Privette, M., Fregly, M., Rowland, N., Sun, Z., Zele, V., Wagemaker, H., & Edelstein, C. (2000). Autism and Schizophrenia: Intestinal Disorders. Nutritional neuroscience, 3(1), 57–72. https://doi.org/10.1080/1028415X.2000.11747303
- Pal, S., Woodford, K., Kukuljan, S., & Ho, S. (2015). Milk Intolerance, Beta-Casein and Lactose. Nutrients, 7(9), 7285-7297. https://doi.org/10.3390/nu7095339
- Chia, J. S. J., McRae, J. L., Kukuljan, S., Woodford, K., Elliott, R. B., Swinburn, B., & Dwyer, K. M. (2017). A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes. Nutrition & diabetes, 7(5), e274. https://doi.org/10.1038/nutd.2017.16
- Sun, Z., Zhang, Z., Wang, X., Cade, R., Elmir, Z., & Fregly, M. (2003). Relation of beta-casomorphin to apnea in sudden infant death syndrome. Peptides, 24(6), 937–943. https://doi.org/10.1016/s0196-9781(03)00156-6
- Ramabadran, K., & Bansinath, M. (1988). Opioid peptides from milk as a possible cause of sudden infant death syndrome. Medical hypotheses, 27(3), 181–187. https://doi.org/10.1016/0306-9877(88)90138-7
- Chin-Dusting, J., Shennan, J., Jones, E., Williams, C., Kingwell, B., & Dart, A. (2006). Effect of dietary supplementation with beta-casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. The British journal of nutrition, 95(1), 136–144. https://doi.org/10.1079/bjn20051599
- Steinerová, A., Racek, J., Stozický, F., Tatzber, F., & Lapin, A. (1999). Autoantibodies against oxidized LDL in the first phase of life. Low density lipoproteins. Clinical chemistry and laboratory medicine, 37(9), 913–917. https://doi.org/10.1515/CCLM.1999.135
- Steinerová, A., Korotvicka, M., Racek, J., Rajdl, D., Trefil, L., Stozický, F., & Rokyta, Z. (2004). Significant increase in antibodies against oxidized LDL particles (IgoxLDL) in three-month old infants who received milk formula. Atherosclerosis, 173(1), 147–148. https://doi.org/10.1016/j.atherosclerosis.2003.12.006
- Laugesen, M., & Elliott, R. (2003). Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. The New Zealand medical journal, 116(1168), U295. [PubMed]
Related Posts
Do you have any questions about nutrition and health?
I would love to hear from you and answer them in my next post. I appreciate your input and opinion and I look forward to hearing from you soon. I also invite you to follow us on Facebook, Instagram, and Pinterest for more diet, nutrition, and health content. You can leave a comment there and connect with other health enthusiasts, share your tips and experiences, and get support and encouragement from our team and community.
I hope that this post was informative and enjoyable for you and that you are prepared to apply the insights you learned. If you found this post helpful, please share it with your friends and family who might also benefit from it. You never know who might need some guidance and support on their health journey.
– You Might Also Like –

Learn About Nutrition
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Medical Disclaimer
GoVeganWay.com brings you reviews of the latest nutrition and health-related research. The information provided represents the personal opinion of the author and is not intended nor implied to be a substitute for professional medical advice, diagnosis, or treatment. The information provided is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.NEVER DISREGARD PROFESSIONAL MEDICAL ADVICE OR DELAY SEEKING MEDICAL TREATMENT BECAUSE OF SOMETHING YOU HAVE READ ON OR ACCESSED THROUGH GoVeganWay.com
NEVER APPLY ANY LIFESTYLE CHANGES OR ANY CHANGES AT ALL AS A CONSEQUENCE OF SOMETHING YOU HAVE READ IN GoVeganWay.com BEFORE CONSULTING LICENCED MEDICAL PRACTITIONER.
In the event of a medical emergency, call a doctor or 911 immediately. GoVeganWay.com does not recommend or endorse any specific groups, organizations, tests, physicians, products, procedures, opinions, or other information that may be mentioned inside.
Editor Picks –
Milos Pokimica is a doctor of natural medicine, clinical nutritionist, medical health and nutrition writer, and nutritional science advisor. Author of the book series Go Vegan? Review of Science, he also operates the natural health website GoVeganWay.com
Latest Articles –
Plant Based News
-
UK Shift To Plant-Based Diets Could Save 58% Of Projected Species Extinctions, Says Report
on September 9, 2025
-
Pomegranate Molasses Bean Salad
on September 9, 2025
-
Eating Plant-Based Can Reduce Cancer And Cardiometabolic Disease Risk, Says Study
on September 8, 2025
-
Homemade Crispy Chili Oil
on September 8, 2025
-
Lidl Beats Own Plant-Based Sales Target With Nearly 700% Uptake
on September 7, 2025
-
This High Fiber Chocolate Mousse Is Gluten-Free And Vegan
on September 7, 2025
-
Lemongrass Tofu Bánh Mì
on September 6, 2025
Top Health News — ScienceDaily
- How orangutans thrive in feast and famine without gaining weighton September 9, 2025
Orangutans, humans’ close evolutionary relatives, have developed remarkable strategies to survive in the unpredictable rainforests of Borneo. A Rutgers-led study reveals that these apes balance protein intake and adjust their activity to match food availability, avoiding obesity and metabolic disease. Unlike humans, who often overeat processed foods without adjusting energy use, orangutans switch between fruits, leaves, and even stored body fat depending on the season. Their ability to […]
- Smog in the brain: Dirty air speeds Alzheimer’s declineon September 9, 2025
Scientists have discovered that even short-term exposure to polluted air can speed up Alzheimer’s, worsening toxic protein buildup in the brain and accelerating memory loss. The research connects fine particulate matter (PM2.5) from sources like smoke and traffic directly to faster cognitive decline.
- The sleep switch that builds muscle, burns fat, and boosts brainpoweron September 9, 2025
UC Berkeley researchers mapped the brain circuits that control growth hormone during sleep, uncovering a feedback system where sleep fuels hormone release, and the hormone regulates wakefulness. The discovery helps explain links between poor sleep, obesity, diabetes, and cognitive decline, while opening new paths for treating sleep and metabolic disorders.
- Seven blood molecules that could explain why you’re always sleepyon September 9, 2025
Scientists discovered seven molecules in the blood linked to excessive daytime sleepiness, a condition that affects one in three Americans and raises the risk of heart disease, obesity, and diabetes. The study highlights the role of both diet and hormones, finding that omega-3 and omega-6 fatty acids may protect against drowsiness, while compounds like tyramine may worsen it.
- Scientists may have found a way to strengthen bones for lifeon September 8, 2025
Scientists at Leipzig University have identified a little-known receptor, GPR133, as a key player in bone health. By stimulating this receptor with a new compound called AP503, they were able to boost bone strength in mice, even reversing osteoporosis-like conditions. The breakthrough highlights a promising path toward safer and more effective treatments for millions struggling with bone loss, while also hinting at broader benefits for aging populations.
- Why the flu turns deadly for older adults, and how scientists found the causeon September 8, 2025
Researchers have uncovered why older adults are more vulnerable to severe flu. The culprit is a protein called ApoD, which rises with age and disrupts the body’s ability to fight infection. This protein damages lung tissue and weakens immune defenses, leading to worse outcomes. By pinpointing ApoD as the driver, scientists now see a promising new treatment target that could protect elderly patients from life-threatening influenza and dramatically cut flu-related deaths.
- Salmon’s secret superfood is smaller than a grain of salton September 8, 2025
Tiny diatoms and their bacterial partners act as nature’s nutrient factories, fueling insects and salmon in California’s Eel River. Their pollution-free process could inspire breakthroughs in sustainable farming and energy.
PubMed, #vegan-diet –
- Knowledge of and attitudes towards vegan and vegetarian diets amongst students at a university located in rural Polandon September 8, 2025
Background: Healthy plant-based diets, such as vegan and vegetarian diets, as well as planetary health diets, meet the recommendations of sustainable dietary patterns and are healthier for both the planet and humans. The adoption of these dietary patterns may depend on socio-demographic factors and individual motivations. Aim: This study aimed to analyse the association between socio-demographic factors and knowledge and attitudes towards vegan and vegetarian diets amongst university […]
- The association between ‘Vegetarian for Life’ diet quality, social connection and depressive symptoms within Western and Indian regional groupson September 5, 2025
CONCLUSIONS: The results underscore the importance of considering socio-cultural dimensions to adherence to dietary patterns, the context of dietary quality and social connection when examining depressive symptoms.
- Effects of vegetarian and vegan diets on disease activity, pain, fatigue, and physical function in patients with rheumatoid arthritis: a systematic review and meta-analysison September 4, 2025
CONCLUSION: The meta-analysis suggests potential beneficial effects on pain. However, due to the methodological limitations and the small number of studies included, definitive conclusions cannot yet be drawn. Future research is needed to further explore the effects of vegetarian and vegan diets.
- Vegetarian diets for longevity: friend or foe?on September 3, 2025
Vegetarianism is a healthy dietary pattern that is postulated to increase longevity. Vegetarianism is adopted for animal ethics, environmental reasons, or religious beliefs. Vegetarian diets are believed to improve the gut microbiome, body weight, cardiovascular health and inflammation; however, a synthesis of the up-to-date evidence does not seem to support these effects. When objective measures are sought, it becomes apparent that there is a lack of high-quality evidence regarding the […]
- Vegan and Plant-Based Diets in the Management of Metabolic Syndrome: A Narrative Review from Anti-Inflammatory and Antithrombotic Perspectiveson August 28, 2025
Metabolic syndrome (MetS) is defined by a combination of metabolic abnormalities, such as central obesity, insulin resistance, hypertension, and dyslipidemia, and significantly increases the risk of cardiovascular diseases and type 2 diabetes. The high prevalence of MetS is a public health concern, necessitating rapid identification and intervention strategies to prevent this emerging epidemic. Diagnosing MetS requires the presence of three or more of these abnormalities, underscoring the […]
Random Posts –
Featured Posts –

Latest from PubMed, #plant-based diet –
- Green tea extract complex as a phytogenic supplement to reduce bile salt hydrolase activity and enhance growth performance in weaning pigsby Sungbo Cho on September 9, 2025
The post-weaning period is stressful for pigs due to changes in their environment and diet. The occurrence of diarrhea at this stage is high. Growth promoters such as antibiotics and zinc oxide (ZnO) have been used to not only reduce post-weaning diarrhea but also improve growth performance of weaning pigs. It has also been shown that the growth performance of pigs is negatively associated with bile salt hydrolase (BSH) in the gut. Antibiotic growth promoters (AGP) and ZnO administration have…
- Effects of isoflavone supplementation, via red clover hay, on the growth and postgraze physiological recovery of beef steers grazing endophyte-infected tall fescue pasturesby Brittany E Davis on September 9, 2025
Livestock grazing endophyte-infected (E+) tall fescue can exhibit persistent systemic vasoconstriction and fescue toxicosis. Isoflavones in legumes, most notably red clover (RC), are known hypotensive agents. The objective of the experiment was to evaluate the effect of isoflavone supplementation via RC hay, every day or every other day (QOD), on average daily gain (ADG) of steers grazing E+ tall fescue pastures and their physiological recovery after grazing when managed on a non-toxic diet…
- Metabolic consequences and gut microbiome alterations in rats consuming pork or a plant-based meat analogueby Thomas Van Hecke on September 9, 2025
It is unknown how human health is affected by the current increased consumption of ultra-processed plant-based meat analogues (PBMA). In the present study, rats were fed an experimental diet based on pork or a commercial PBMA, matched for protein, fat, and carbohydrate content for three weeks. Rats on the PBMA diet exhibited metabolic changes indicative of lower protein digestibility and/or dietary amino acid imbalance, alongside increased mesenteric (+38%) and retroperitoneal (+20%) fat…
- Inadequate Micronutrient Intakes: Exploring the Vitamin and Mineral Intakes and Food Sources of New Zealand Aged-Care Residentsby Sue O MacDonell on September 9, 2025
CONCLUSIONS: Older residents had a high prevalence of inadequate usual intakes of multiple micronutrients. Both animal and plant-based food groups were important sources of vitamins and minerals, and further work is needed to develop practical policies and methods of ensuring nutritional adequacy in this setting.
- Dietary Nigella sativa oil confers protection against diazinon toxicity in nile tilapia (Oreochromis niloticus): A detoxification-based approachby Mustafa Öz on September 9, 2025
This study evaluated how dietary black seed oil (Nigella sativa L.) against the diazinon waterborne toxicity on Nile tilapia (Oreochromis niloticus), focusing on growth performance, hematological and biochemical parameters as well as oxidative stress markers and histological changes. A 40-day feeding trial was carried out using four experimental groups: Group 1 (control group), Group 2 (N. sativa-supplemented group), Group 3 (diazinon-exposed group), and Group 4 (diazinon-exposed with N. […]
- csi-miR166e, A Microribonucleic Acid of Considerable Abundance in Plant Food, Ameliorates High-Fat Diet/Streptozotocin-Induced Type 2 Diabetes in Mice via Oral Administrationby Ying Li on September 8, 2025
Diet regimes rich in fruits and vegetables have been adopted as effective strategies for the management of type 2 diabetes mellitus (T2DM). Here, we identified miR166e, a plant miRNA abundantly present in fruits and vegetables, as a functional agent that ameliorates T2DM in a mouse model. Orally administered miR166e oligomers passed through digestion, accumulated in the intestines at 14.1 ± 6.1 fM, and significantly improved glycemic parameters, including fasting blood glucose, HbA1c, and…